Gut Microbiota Play an Essential Role in the Antidiabetic Effects of Rhein.

Gut Microbiota Play an Essential Role in the Antidiabetic Effects of Rhein.
复制标题

DOI:
10.1155/2018/6093282
复制
发表时间:
2018
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
通讯作者:
Du H
Du H
中科院分区:
其他
文献类型:
--
作者:
Wang R;Zang P;Chen J;Wu F;Zheng Z;Ma J;Yang C;Du H

文献摘要

参考文献

被引文献

相似文献

很明显,肠道菌群可以影响宿主的代谢,肠道菌群的改变与代谢性疾病有关。莱茵已被用于中药中,被认为具有抗糖尿病作用。本研究表明,口服大黄素6周可显著降低空腹血糖(FBG)水平(8.30±4.52 mmol/l vs 18.89±6.06 mmol/l, p < 0.01),提高活性胰高血糖素样肽1 (GLP-1)水平(22.21±2.61 pmol/l vs 14.46±5.22 pmol/l, p < 0.05),增加回肠末端l细胞数量。大黄酸与广谱抗生素联用对db/db小鼠的降糖作用完全消失。我们观察到,大黄酸处理小鼠的Bacteroidetes丰度增加(0.361±0.022比0.185±0.055,p < 0.05,)。此外,大黄碱处理组与对照组之间多样性无显著差异(Shannon指数:p = 0.88; Simpson指数:p = 0.86)。综上所述,我们的研究结果表明,肠道微生物群的调节可能在大黄酸的抗糖尿病作用中发挥重要作用。
It is clear that the gut microbiota can affect host metabolism and alterations of the gut microbiota can link with metabolic disease. Rhein has been used in traditional Chinese medicine with putative antidiabetic effects. Here we show that oral administration of rhein for 6 weeks can significantly reduce fasting blood glucose (FBG) level (8.30 ± 4.52 mmol/l versus 18.89 ± 6.06 mmol/l, p < 0.01), elevate the active glucagon-like peptide 1 (GLP-1) level (22.21 ± 2.61 pmol/l verss 14.46 ± 5.22 pmol/l, p < 0.05), and increase the number of L-cells in the terminal ileum. The antidiabetic effect of rhein is abrogated in db/db mice treated with rhein in combination with broad-spectrum antibiotics. We observed that the abundance of the Bacteroidetes is increased in mice treated with rhein (0.361±0.022 versus 0.185 ± 0.055, p < 0.05,). In addition, there is no significant difference in diversity between rhein-treated groups and the controls (Shannon index: p = 0.88; Simpson index: p = 0.86). Taken together, our results indicate that modulation of the gut microbiota may play an essential role in the antidiabetic effects of rhein.
DOI: 10.2337/db11-1019
发表时间: 2012-02
期刊: Diabetes
影响因子: 7.7
作者:
Tolhurst G;Heffron H;Lam YS;Parker HE;Habib AM;Diakogiannaki E;Cameron J;Grosse J;Reimann F;Gribble FM
通讯作者: Gribble FM
DOI: 10.1053/j.gastro.2012.06.031
发表时间: 2012-10-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Vrieze, Anne;Van Nood, Els;Nieuwdorp, Max
通讯作者: Nieuwdorp, Max
DOI: 10.1038/bjp.2008.26
发表时间: 2008-04-01
影响因子: 7.3
作者:
Zheng, J-M;Zhu, J-M;Liu, Z-H
通讯作者: Liu, Z-H
DOI: 10.1136/gutjnl-2014-306928
发表时间: 2014-09-01
期刊: GUT
影响因子: 24.5
作者:
Tilg, Herbert;Moschen, Alexander R.
通讯作者: Moschen, Alexander R.
DOI: 10.2337/dc16-1324
发表时间: 2017-01-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
de la Cuesta-Zuluaga, Jacobo;Mueller, Noel T.;Escobar, Juan S.
通讯作者: Escobar, Juan S.